Sabre Corporation (SABR)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-358.54	-278.76	-527.61	-435.45	-928.47	-1,282
Depreciation & Amortization	54.54	57.92	59.65	73.65	95.44	123.65
Other Amortization	137.61	135	146.61	171.09	236.3	324.4
Loss (Gain) From Sale of Assets	-5.19	-	-	-180.08	-14.53	-
Asset Writedown & Restructuring Costs	-	-	-	5.15	-	8.68
Loss (Gain) From Sale of Investments	-2.03	-3.23	2.4	26	-	-
Stock-Based Compensation	54.81	54.57	52.02	82.87	120.89	69.95
Provision & Write-off of Bad Debts	-2.43	2.06	5.87	-0.29	-7.79	65.71
Other Operating Activities	17.94	157.53	180.82	4.29	4.91	49.38
Change in Accounts Receivable	-62.45	13.33	-1.45	-122.29	-17.88	204.97
Change in Accounts Payable	41.94	32.71	60.53	131.03	70.35	-304.05
Change in Unearned Revenue	-15.81	-38.28	52.18	-15.51	-4.52	15.36
Change in Other Net Operating Assets	-41.77	-62.24	25.23	-16.94	30.64	-45.96
Operating Cash Flow	-193.45	70.59	55.81	-279.72	-418.15	-773.18
Operating Cash Flow Growth	-	26.48%	-	-	-	-
Capital Expenditures	-77.75	-84.15	-87.42	-69.49	-54.3	-65.42
Cash Acquisitions	-	-	-12.02	-68.8	-	-
Investment in Securities	54.83	54.83	-11.2	312.27	24.87	68.5
Other Investing Activities	-0.2	-0.3	0.66	-	-	-4.38
Investing Cash Flow	-13.85	-29.61	-109.98	173.98	-29.43	-1.29
Long-Term Debt Issued	-	1,939	1,749	1,819	1,070	2,982
Long-Term Debt Repaid	-	-1,842	-1,682	-1,823	-1,064	-1,534
Net Debt Issued (Repaid)	101.65	96.56	66.74	-4.08	6.79	1,448
Issuance of Common Stock	-	-	-	-	-	275
Preferred Dividends Paid	-	-	-16.04	-21.39	-21.63	-5.85
Common Dividends Paid	-	-	-	-	-	-38.54
Dividends Paid	-	-	-16.04	-21.39	-21.63	-44.39
Other Financing Activities	-81.7	-56.99	-144.92	-49.91	-35.72	-164.16
Financing Cash Flow	19.95	39.57	-94.22	-75.37	-50.56	1,838
Foreign Exchange Rate Adjustments	0.84	-4.28	1.71	-2.36	-2.14	0.22
Net Cash Flow	-186.51	76.27	-146.68	-183.47	-500.27	1,063
Free Cash Flow	-271.2	-13.55	-31.61	-349.21	-472.45	-838.6
Free Cash Flow Margin	-9.01%	-0.45%	-1.09%	-13.76%	-27.97%	-62.86%
Free Cash Flow Per Share	-0.70	-0.04	-0.09	-1.07	-1.47	-2.89
Cash Interest Paid	382.97	382.97	394.54	286.14	246.93	186.24
Cash Income Tax Paid	18.32	18.32	24.33	15.62	14.66	24.51
Levered Free Cash Flow	88.27	67.18	98.23	-50.35	-83.37	-382.99
Unlevered Free Cash Flow	370.64	356.58	355.41	118.15	65.78	-251.51
Change in Working Capital	-78.09	-54.49	136.49	-23.7	78.59	-129.68

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q